SCHEMBL14929935

SCHEMBL14929935

Cc1cncc(Nc2nc(NC3CCCC[C@@H]3N)c(Cl)cc2C(N)=O)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FER P16591 6/20 0.76
▸ SYK P43405 13/20 0.57
▸ MAPK3 P27361 3/20 0.55
▸ MAPK1 P28482 3/20 0.55
▸ KCNH2 Q12809 3/20 0.55
▸ AURKB Q96GD4 3/20 0.55
▸ GP6 Q9HCN6 1/20 0.55
▸ JAK2 O60674 1/20 0.50
▸ ROCK2 O75116 1/20 0.50
▸ MAP4K4 O95819 1/20 0.50
▸ HCK P08631 1/20 0.50
▸ ROS1 P08922 1/20 0.50
▸ PIM1 P11309 1/20 0.50
▸ PRKACA P17612 1/20 0.50
▸ MARK3 P27448 1/20 0.50
▸ LTK P29376 1/20 0.50
▸ FLT3 P36888 1/20 0.50
▸ CSNK1A1 P48729 1/20 0.50
▸ CLK2 P49760 1/20 0.50
▸ MAPK10 P53779 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909511 1.00 FER (0.76) FERSYKMAPK3MAPK1KCNH2
SCHEMBL14909512 1.00 FER (0.76) FERSYKMAPK3MAPK1KCNH2
Hydrochloric Acid SCHEMBL14911570 0.99 FER (0.75) FERSYKMAPK3MAPK1KCNH2
Hydrochloric Acid SCHEMBL14911571 0.99 FER (0.75) FERSYKMAPK3MAPK1KCNH2
SCHEMBL3363567 0.89 FER (0.60) FERSYKMAPK3MAPK1KCNH2
SCHEMBL14923817 0.89 FER (0.60) FERSYKMAPK3MAPK1KCNH2
SCHEMBL14929521 0.89 FER (0.60) FERSYKMAPK3MAPK1KCNH2
SCHEMBL14910635 0.89 FER (0.60) FERSYKMAPK3MAPK1KCNH2
SCHEMBL14929939 0.89 FER (0.60) FERSYKMAPK3MAPK1KCNH2
SCHEMBL14909843 0.89 FER (0.60) FERSYKMAPK3MAPK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 — — US disclosed
US-8809371-B2 — — 2014-08-19 — — US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK FER 919/4885SYK 1/4885MAPK3 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback